Russell Cohen, MD, Discusses Medication Adherence in Inflammatory Bowel Disease
Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines." There have been many breakthroughs in medication adherence for managing IBD. For instance, Dr Cohen says once-a-day dosing ensures patients don't fall behind in taking their prescribed medications.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
The Genetic Information Nondiscrimination Act (GINA) protects most consumers from losing health coverage or their job if they pursue genetic testing. But authors of a new article in The New England Journal of Medicine explore the implications of testing for life, disability and long-term care insurance.
Meeting enrollment goals for the Affordable Care Act proved the easy part for the HHS in 2015. The hard part will come March 4, 2015, when the US Supreme Court will hear a case that could eliminate financial subsidies for millions who signed up, putting their health coverage at risk.
Hospital leaders express the same concerns heard in Florida, Alabama, and elsewhere since the midterms: refusing to expand Medicaid to the working poor leaves thousands without coverage, and they still come to emergency rooms for routine care. The problem is, the Affordable Care Act assumed that expansion would be universal, and funds to care for the uninsured have dried up.
As the personalized medicine initiative takes shape, word comes that CMS will pay for key genetic tests in lung cancer. This policy shift is a sea change after a long period of frustration for test makers in seeking reimbursement.